Press Release – New York, NY – August 12, 2026 – Sichenzia Ross Ference Carmel LLP announced that it represented JonesTrading as the sole book-running manager for the recently priced $81.3 million initial public offering of Vogenx, Inc. (Nasdaq: VOGX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia and gastroparesis.
The JonesTrading team was led by Moe Cohen, Michael Truettner, Brian Gallagher and Jonah Viroslav.
The SRFC team was led by partners Ross Carmel and Matthew Siracusa, with associate Tong Wu.